Synthetic Lethality Conference

Страна: США

Город: Boston

Тезисы до: 30.01.2018

Даты: 31.01.18 — 01.02.18

Е-мейл Оргкомитета:

Организаторы: Hanson Wade


The Synthetic Lethality Summit is the first industry-dedicated meeting that focuses on the research and development of synthetic lethal drugs, providing safe and effective treatments for a range of cancers and other diseases.

Across 3 content-packed days, the field’s thought leaders from AstraZeneca, Tesaro, Artios, Metabomed, Sierra Oncology and many more will be sharing their insight and lessons learned, collectively enabling the community to:

    Achieve Efficacy across Contexts: Define the key steps required to identify and therapeutically exploit robust synthetic lethal interactions that are conserved across a variety of defined contexts

    Optimize Patient Stratification: Streamline clinical trials by improving the recruitment and stratification of patients, increasing efficiency

    Apply Lessons Learned from PARP Inhibitors: Analyze key aspects of the development of PARP inhibitors through case studies, and determine how we can use these insights to advance R&D of new synthetic lethal drugs

    Exploit Key Targets of Mechanisms of Resistance: Assess the most effective methods for identifying and utilizing mechanisms of resistance to optimize cancer treatment

    Harness Bioinformatics and Computational Approaches: Exploring the latest advances in identifying clinically relevant synthetic lethal interactions from genome widescreens

Join your peers in Boston to gain unique and novel insights into methods for accelerating your synthetic lethal drug development.


Веб-сайт конференции:

Конференции по теме - с близкими дедлайнами: